Navigation Links
InterMune Reports First Quarter 2011 Financial Results and Business Highlights
Date:4/28/2011

mune.com.Actimmune® and Esbriet® are registered trademarks of InterMune, Inc.  

Financial tables follow:InterMune, Inc.PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited, in thousands, except per share amounts)Three Months EndedMarch 3120112010Revenue, net  Actimmune

$

5,052$

5,264  Collaboration revenue1,300818   Total revenue, net6,3526,082Costs and expenses:  Cost of goods sold2,2862,643  Research and development16,83820,477  General and administrative17,57615,131Total costs and expenses36,70038,251Loss from operations(30,348)(32,169)Interest income138177Interest expense(1,787)(2,101)Other income (expense)(106)15Loss from operations before income taxes(32,103)(34,078)Income tax expense (benefit)--Net loss

$

(32,103)$

(34,078)Basic and diluted loss per share:Net loss per share

$

(0.57)$

(0.66)Shares used in computing basic and diluted net loss per share56,37751,930InterMune, Inc.PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS(unaudited, in thousands)March 31December 31,20112010Cash, cash equivalents and available-for-sale securities

$

254,282$

295,073Acquired product rights20,000-Other assets11,35110,074  Total assets

$

285,633$

305,147Total other liabilities

$

24,692$

26,547Convertible senior notes85,000129,300Stockholders’ equity (deficit)175,941149,300  Total liabilities and stockholders’ equity (deficit)

$

285,633$

305,147
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. InterMune to Present at Canaccord Adams Conference
2. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
3. InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
4. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
5. InterMune to Release Third Quarter 2008 Financial Results on November 6
6. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
7. InterMune to Present at Deutsche Bank Biotech Boston Confab
8. InterMune to Present at J.P. Morgan Healthcare Conference
9. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
10. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
11. InterMune Announces Issuance of U.S. Patent for ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Mich. , May 6, 2015 Paradigm ... will give the keynote address at the International Society ... in Phoenix, AZ at 9:45 ... The Odyssey" will focus on the historic and critical ... in shaping our personalized medicine revolution.  Furthermore, he will ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 ... Dots, a type of nanomaterial with diameter ranging ... product in the global nanophotonics materials market. The ... quantum dots due to quantum confinement effect render ... a wide range of scientific, technological, and commercial ...
(Date:5/6/2015)... , May 6, 2015  Northwest Biotherapeutics (NASDAQ: NWBO) ... therapies for solid tumor cancers, today announced that Linda Powers ... the Company,s DCVax cancer vaccine platform for solid tumor cancers ... 7, 2015.   , , , ... , , , TIME: , , , 12:15 PM EDT ...
(Date:5/6/2015)... , May 6, 2015 ... membrane specialist, announced today that it has signed an ... Ethanol, Inc. (Nasdaq: PEIX ) for the delivery of an industrial ... reduce the consumption of water, energy and ... output. This project is fully ...
Breaking Biology Technology:Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 2Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference 3Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 2NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2
... , PRINCETON, N.J., July 28 ... production company, today announced the appointment of Daniel E. ... will be responsible for Laureate,s worldwide business development activities, ... the company,s contract development, manufacturing, and bioprocessing business. ...
... , DOYLESTOWN, Pa., July 28 RadMD, Inc. ... offer a broad range of accredited CME courses in the area ... , , The comprehensive education and training is ... RadMD is partnering with International Center for Postgraduate Medical Education (ICPME) ...
... , CINCINNATI, July 27 Kendle (Nasdaq: ... organization, today appointed Stephen Cutler, PhD, as the Company,s new ... Dr. Cutler brings to Kendle more than 20 years of ... biopharmaceutical industries to position the Company for continued growth as ...
Cached Biology Technology:Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development 2RadMD First to Offer CME-Certified Education and Training For Medical Imaging in Clinical Trials 2Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer 2Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer 3
(Date:3/24/2015)... Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of ... report to their offering. This report analyzes the ... the following Segments: Face Biometrics, and Voice Biometrics. The report provides ... Japan , Europe , ... Africa , and Latin America ...
(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
Breaking Biology News(10 mins):Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
... chemistry and biology now have access to one of the ... new Spectral Imaging Facility, opened this fall, is a combination ... microscope, the first commercial machine of its kind. , The ... Barbara and the confocal microscope system by Olympus America Inc. ...
... genetic interactions promises to change how researchers study the ... is called epistatic mini array profiles (E-MAP), has already ... to uncover the roles of previously uncharacterized proteins, and ... one another. , E-MAP will enable new understanding ...
... newly identified gene expression profile could help predict how ... treatment. Described in a study in the November 1, ... the new findings further establish an important role for ... in ovarian cancer, and could eventually provide clinicians with ...
Cached Biology News:Technique offers new view of dynamic biological landscape 2Technique offers new view of dynamic biological landscape 3Technique offers new view of dynamic biological landscape 4Gene expression profile helps predict chemotherapy response in ovarian cancer patients 2Gene expression profile helps predict chemotherapy response in ovarian cancer patients 3
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
... Synthetic peptide corresponding to ... Antigen Family: Regulator ... Subfamily: not assigned-Regulator ... Storage: Long term: ...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
... both gel dimensions in the same cell. Up to ... a single run using the tube gel adaptors, which ... manner as the slab gel assembly. While the tube ... cast in the casting stand. The 20 cm long ...
Biology Products: